APP下载

初诊急性心肌梗死患者血清N末端脑钠肽前体及D-二聚体水平与预后的关系研究

2020-12-23王新宙贾艳静

中国实用医药 2020年31期
关键词:急性心肌梗死

王新宙 贾艳静

【摘要】 目的 探討初诊急性心肌梗死患者血清N末端脑钠肽前体(NT-proBNP)及D-二聚体(D-Dimer)水平与预后的关系。方法 选取80例初诊急性心肌梗死患者作为观察组, 同时选择同期的80例体检健康者作为健康对照组。比较两组受试者D-Dimer、NT-proBNP水平, 观察组不同心功能分级患者、不同冠状动脉造影情况患者、是否发生心血管事件患者、死亡与存活患者的D-Dimer、NT-pro BNP水平。结果 观察组患者D-Dimer为(513.72±55.67)mg/ml、NT-proBNP为(2749.62±449.51)ng/L均高于健康对照组的(127.67±32.43)mg/ml、NT-proBNP(462.36±134.57)ng/L, 两组数据经检验均符合正态分布, 且方差齐, 差异有统计学意义(P<0.05)。观察组Ⅰ级患者D-Dimer水平(512.73±11.47)mg/ml、NT-proBNP为(2217.16±317.52)ng/L, 均最低;Ⅳ级患者D-Dimer(579.31±26.42)mg/ml、NT-proBNP(2752.27±367.42)ng/L, 均最高。随着心功能分级的增加, 患者D-Dimer、NT-proBNP的水平也随之增高, 差异均具有统计学意义(P<0.05)。观察组冠状动脉单支病变患者D-Dimer、NT-proBNP水平最低, 分别为(473.61±16.72)mg/ml、(2181.73±289.39)ng/L, 冠状动脉三支病变患者D-Dimer、NT-proBNP水平最高, 分别为(576.65±26.57)mg/ml、(2779.32±396.43)ng/L, 随着患者患病支数增加, 患者的D-Dimer、NT-proBNP水平越高, 差异均有统计学意义(P<0.05)。观察组未发生心血管事件的患者D-Dimer为(426.57±31.12)mg/ml、NT-proBNP为(2153.31±416.27)ng/L均低于发生心血管事件患者的(562.71±51.53)mg/ml、(2799.87±452.13)ng/L, 差异均有统计学意义(P<0.05)。观察组死亡患者D-Dimer为(962.71±142.61)mg/ml、NT-proBNP为(9239.21±1452.47)ng/L均高于存活患者的(502.56±97.72) mg/ml、(2353.31±506.97)ng/L, 差异均有统计学意义(P<0.05)。结论 D-Dimer与NT-proBNP在急性心肌梗死患者的诊断中有着良性的指导作用, 随着患者疾病程度的加重, D-Dimer、NT-proBNP的水平也在随之升高, 同时患者D-Dimer、NT-proBNP的水平越高, 患者的预后也就越差, 在临床中对于D-Dimer、NT-proBNP的水平应引起重视。

【关键词】 急性心肌梗死;N末端脑钠肽前体;D-二聚体;预后

DOI:10.14163/j.cnki.11-5547/r.2020.31.003

Study on the correlation between serum N-terminal pro-brain natriuretic peptide and D-Dimer levels and prognosis in patients with newly diagnosed acute myocardial infarction   WANG Xin-zhou, JIA Yan-jing. Linfen Vocational and Technical College, Linfen 041000, China

【Abstract】 Objective   To discuss the correlation between serum N-terminal pro-brain natriuretic peptide (NT-proBNP) and D-Dimer levels and prognosis in patients with newly diagnosed acute myocardial infarction. Methods   There were 80 patients with newly diagnosed acute myocardial infarction selected as the observation group, and 80 healthy subjects during the same period as the healthy control group. Comparison was made on levels of D-Dimer and NT-proBNP between the two groups, the levels of D-Dimer and NT-proBNP in patients with different cardiac function classifications, patients with different coronary angiography conditions, patients with cardiovascular events, death and surviving patients in the observation group. Results   D-Dimer (513.72±55.67) mg/ml and NT-proBNP (2759.62±449.51) ng/L of the observation group were higher than (127.67±32.43) mg/ml and (462.36±134.57) ng/L of healthy control group, and the difference was statistically significant (P<0.05). In the observation group, the levels of D-Dimer and NT-proBNP in grade Ⅰ patients were (512.73±11.47) mg/ml and (2217.16±317.52) ng/L, which were the lowest; D-Dimer level and NT-proBNP level of grade Ⅳ patients were (579.31±26.42) mg/ml and (2742.27±367.42) ng/L, which were the highest. With the increase of cardiac function classification, the levels of D-Dimer and NT-proBNP were also increased, the differences were statistically significant (P<0.05). In the observation group, the levels of D-Dimer and NT-proBNP in patients with single-vessel coronary artery disease were the lowest, which were (473.61±16.72) mg/ml and (2181.73±289.39) ng/L, respectively. The levels of D-Dimer and NT-proBNP in patients with three-vessel coronary artery disease were the highest, which were (576.65±26.57) mg/ml and (2779.32±396.43) ng/L, respectively. With the increase of the number of diseased vessel, the higher the level of D-Dimer and NT-proBNP, and the difference was statistically significant (P<0.05). In the observation group, D-Dimer and NT-proBNP of patients without cardiovascular events were (426.57±31.12) mg/ml and (2153.31±416.27) ng/L, which were lower than those of patients with cardiovascular events (562.71±51.53) mg/ml, (2799.87±452.13) ng/L, and the difference was statistically significant (P<0.05); D-Dimer (962.71±142.61) mg/ml and NT-proBNP (9239.21±1452.47) ng/L of dead patients were higher than those of surviving patients (502.56±97.72) mg/ml and (2353.31±506.97) ng/L, and the differences were statistically significant (P<0.05). Conclusion   D-Dimer and NT-proBNP have a benign guiding role in the diagnosis of patients with acute myocardial infarction. With the aggravation of the disease, the levels of D-Dimer and NT-proBNP are also increasing. At the same time, the higher the level of D-Dimer and NT-proBNP, the worse the prognosis of patients. Attention should be paid to the levels of D-Dimer and NT-proBNP in clinical practice.

【Key words】 Acute myocardial infarction; N-terminal pro-brain natriuretic peptide; D-Dimer; Prognosis

急性心肌梗死是临床常见的心内科急危重疾病[1]。现阶段急性心肌梗死的诊断多凭借肌钙蛋白的升高与心电图的改变来确定, 所以如何提高急性心肌梗死患者的诊断效率, 同时对患者预后情况的评估成为现阶段的研究重点[2]。为了探讨初诊急性心肌梗死患者血清N末端脑钠肽及D-二聚体水平与预后的关系, 作者选取本院2019年2月~2020年2月门诊收治的80例初诊急性心肌梗死患者, 同时选择同期的健康体检者80例, 进行临床观察, 现将结果报告如下。

1 资料与方法

1. 1 一般资料 选取本院2019年2月~2020年2月门诊收治的80例初诊急性心肌梗死患者作为观察组, 同时选择同期的80例体检健康者作为健康对照组。观察组中男42例, 女38例;平均年龄(57.57±12.86)岁;单支病变27例, 双支病变29例, 三支病变24例;心功能分级:Ⅰ级23例, Ⅱ级26例, Ⅲ级15例, Ⅳ级16例。健康对照组中男40例, 女40例;平均年龄(58.03±13.12)岁。两组一般资料比较, 差异均无统计学意义(P>0.05), 具有可比性。所……

登录APP查看全文

猜你喜欢

急性心肌梗死
尿激酶溶栓用于老年急性心肌梗死患者的临床护理
心绞痛、急性心肌梗死与甲状腺功能变化的相关性
急性心肌梗死心血管内科治疗的临床研究
急性心肌梗死患者内脏素mRNA基因表达及临床相关性的研究
急性心肌梗死合并左束支阻滞的心电图诊断
优化急诊护理流程对急性心肌梗死患者抢救效果的影响
急诊全程优化护理在抢救急性心肌梗死患者中的应用
阿托伐他汀对老年急性心肌梗死患者经皮冠状动脉介入治疗后心肌损伤的保护作用分析
急性心肌梗死患者的中医辨证治疗分析
替罗非班在急诊PCI术中应用的临床观察